Kuber Drugs Pvt.Ltd. - Company Profile

It is a financial services private limited company based in Kolkata, West Bengal, India, established in 1994.
1994 Kolkata, West Bengal, India Amalgamated
Last Updated:
Access Report
About Kuber Drugs Pvt.Ltd.

Kuber Drugs Pvt.Ltd., a amalgamated private limited company, was established on 14 December 1994 in Kolkata, West Bengal, India. Engaging in financial activities within the financial and insurance service sector, it holds CIN: U51397WB1994PTC066578. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹5.70 M and a paid-up capital of ₹5.68 M.

It upholds a compliant status. Its leadership includes Abha Devi Agarwal (Director), Nehal Agarwal (Director). Past directors included Vishwanath Agarwal, Ishan Agarwal, Nehal Agarwal. Its latest AGM occurred on 29 December 2021, with the balance sheet filed on 31 March 2021. It is based at Offic No. 803, 41A, A.J.C Bose Road Diamond Prestige, 8Th Floor, Kolkata, West Bengal, 700017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51397WB1994PTC066578

  • Registration Number

    066578

  • Incorporation Date

    14 December 1994

  • Authorized Capital

    ₹5.70 M

  • Paid-Up Capital

    ₹5.68 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 5.70 M
  • Paid Up Capital ₹ 5.68 M
  • Company Age 31 Year, 2 Months
  • Last Filing with ROC 31 Mar 2021
Company report

Kuber Drugs Pvt.Ltd.

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kuber Drugs Pvt.Ltd. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kuber Drugs Pvt.Ltd.?
Current Directors
Name Designation Appointment Date Status
Abha Devi Agarwal Director 22 Oct 2021 Current
Nehal Agarwal Director 22 Dec 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jan 2021 Past
Pramod Abcsdd Director 24 Dec 2021 Past
Pramod Abcsdd Director 23 Oct 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kuber Drugs.Ltd..

Kuber Drugs Pvt.Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Kuber Drugs.Ltd. revenue growth over time
Kuber Drugs.Ltd. profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kuber Drugs.Ltd.?

In 2017, Kuber Drugs.Ltd. had a promoter holding of 100.00%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kuber Drugs.Ltd.?

Unlock and access historical data on people associated with Kuber Drugs.Ltd., such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kuber Drugs.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kuber Drugs.Ltd.'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kuber Drugs.Ltd.
Recent Activity within the Organization
  • Annual General Meeting

    Kuber Drugs Pvt.Ltd. last Annual general meeting of members was held on 29 Dec 2021 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    Progress on Nehal Agarwal was appointed as a Director was appointed as a Director on 22 Dec 2021 & has been associated with this company since 4 years 2 months . was documented.

  • Director Appointment

    The activity Abha Devi Agarwal was appointed as a Director was appointed as a Director on 22 Oct 2021 & has been associated with this company since 4 years 4 months . was completed.

  • Balance Sheet

    Kuber Drugs Pvt.Ltd. has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Kolkata. was recorded as a recent event.

  • Company Incorporation

    Progress on Kuber Drugs Pvt.Ltd. was registered on 14 Dec 1994 with Roc Kolkata & aged 31 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kuber Drugs Pvt.Ltd.?

The CIN of Kuber Drugs Pvt.Ltd. is U51397WB1994PTC066578.

Where is Kuber Drugs Pvt.Ltd. headquartered?

Kuber Drugs Pvt.Ltd. is headquartered at Offic No. 803, 41A, A.J.C Bose Road Diamond Prestige, 8Th Floor, Kolkata, West Bengal, 700017.

When was Kuber Drugs Pvt.Ltd. incorporated?

Kuber Drugs Pvt.Ltd. was incorporated on 14 December 1994.

Who are the current directors of Kuber Drugs Pvt.Ltd.?

The current directors of Kuber Drugs Pvt.Ltd. are

What is the primary industry of Kuber Drugs Pvt.Ltd.?

The primary industry of Kuber Drugs Pvt.Ltd. is Financial And Insurance Service.

Is Kuber Drugs Pvt.Ltd. a listed company?

Kuber Drugs Pvt.Ltd. is unlisted.

What is the capital structure of Kuber Drugs Pvt.Ltd.?

The authorized capital of Kuber Drugs Pvt.Ltd. is ₹5.70 M, and the paid-up capital is ₹5.68 M.

What is the compliance status of Kuber Drugs Pvt.Ltd.?

The compliance status of Kuber Drugs Pvt.Ltd. is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available